digital coin market, People searches

Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.CLP Xingfa: At present, the company is not involved in quantum technology or application. CLP Xingfa said on the interactive platform on December 11 that the company is not involved in quantum technology or application at present.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.

Vegetable oil rose by 2.08% on the 11th, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract vegetable oil closed at 2,505, up or down by +2.08%, with a turnover of 727,500 lots. The position data showed that the top 20 seats were net, and the difference position was 2,628 lots. The total turnover of vegetable oil futures contracts was 857,200 lots, an increase of 255,300 lots over the previous day. The first 20 seats in the contract held 240,200 lots, an increase of 6,901 lots over the previous day. The short positions in the top 20 seats of the contract were 239,200 lots, a decrease of 1,059 lots from the previous day. (Sina Futures)Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.Grant Thornton Group, a Hong Kong financial consulting and IPO sponsor service provider, is priced at $ 4-5 per share, and plans to raise $10 million.

Wuzhou Spring Festival rose by 6.55% today. Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and Wuzhou Spring Festival rose by 6.55% today, with a turnover of 3.902 billion yuan and a turnover rate of 37.90%. After-hours data show that Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and the special seat of Shanghai Stock Connect bought 88.9787 million yuan and sold 58.7513 million yuan.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Zhengshang Institute: Xinfengming Jiangsu Xintuo New Materials Co., Ltd. was added as the designated short fiber delivery warehouse. Zhengzhou Commodity Exchange announced on the 11th that after research, Xinfengming Jiangsu Xintuo New Materials Co., Ltd. was added as the designated short fiber delivery warehouse, and the short fiber futures delivery business was started from the date of announcement, with the daily minimum delivery speed of 1,000 tons/day and the premium of 0 yuan/ton.